Skip to main content

'Select agent' clearances delayed

US agencies have completed only about half of inspections as Nov 12 deadline looms

Written byJeffrey Perkel
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00

Critical national biodefense research could be delayed starting November 12, according to the American Society for Microbiology (ASM), unless the federal government delays implementation of new regulations intended to boost security of dangerous biological agents and toxins. However, federal agencies, scrambling to keep up, said the problems are being addressed.

In a pair of letters dated October 23, the ASM requested that the secretaries of Health and Human Services and Agriculture push back the effective date for full compliance with Title II of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002—currently November 12—to give the government more time to vet researchers who wish to work with select agents and to inspect the laboratories in which such work will be performed.

Once Title II, the so-called "select agent rule," is fully implemented, any researcher who has not been cleared to work with select agents will be barred ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo